BACKGROUND: To investigate the role of the therapeutic alliance in predicting length of retention in residential drug treatment. METHODS: The study recruited 187 clients starting residential rehabilitation treatment for drug misuse in three UK services. Counsellor and client information was assessed at intake, and the average total scores of client and counsellor ratings on the WAI-S (obtained during weeks 1-3) were use as the alliance measure. Length of retention and treatment completion (stay beyond 90 days) were used as measures of retention. RESULTS: Clients with weak counsellor rated alliances dropped out of treatment significantly sooner than clients with strong counsellor rated therapeutic alliances, whether or not the model adjusted for individual counsellor effects and potential confounders including psychological well-being, treatment motivation and readiness, coping strategies, and attachment style. The client rated alliance did not predict length of retention. Apart from the alliance, pre-treatment crack use, secure attachment style and better coping strategies were associated with shorter retention, whereas greater confidence in treatment, older client age and better education predicted treatment completion. Counsellors with greater experience of delivering drug counselling retained clients longer. CONCLUSIONS: The findings of this study stress the importance of treatment professionals attending to the therapeutic alliance in drug treatment, as counsellors' alliance ratings were found to be amongst the strongest predictors of dropout. Using alliance measures as clinical tools may help treatment practitioners to become aware of the risk of disengagement early on. Prospective studies are needed to evaluate whether strategies of reallocating clients with poor alliances to different counsellors lead to improvements in retention.
BACKGROUND: To investigate the role of the therapeutic alliance in predicting length of retention in residential drug treatment. METHODS: The study recruited 187 clients starting residential rehabilitation treatment for drug misuse in three UK services. Counsellor and client information was assessed at intake, and the average total scores of client and counsellor ratings on the WAI-S (obtained during weeks 1-3) were use as the alliance measure. Length of retention and treatment completion (stay beyond 90 days) were used as measures of retention. RESULTS: Clients with weak counsellor rated alliances dropped out of treatment significantly sooner than clients with strong counsellor rated therapeutic alliances, whether or not the model adjusted for individual counsellor effects and potential confounders including psychological well-being, treatment motivation and readiness, coping strategies, and attachment style. The client rated alliance did not predict length of retention. Apart from the alliance, pre-treatment crack use, secure attachment style and better coping strategies were associated with shorter retention, whereas greater confidence in treatment, older client age and better education predicted treatment completion. Counsellors with greater experience of delivering drug counselling retained clients longer. CONCLUSIONS: The findings of this study stress the importance of treatment professionals attending to the therapeutic alliance in drug treatment, as counsellors' alliance ratings were found to be amongst the strongest predictors of dropout. Using alliance measures as clinical tools may help treatment practitioners to become aware of the risk of disengagement early on. Prospective studies are needed to evaluate whether strategies of reallocating clients with poor alliances to different counsellors lead to improvements in retention.
Authors: Marna S Barrett; Wee-Jhong Chua; Paul Crits-Christoph; Mary Beth Gibbons; D Casiano; Don Thompson Journal: Psychotherapy (Chic) Date: 2008-06-01
Authors: Lesia M Ruglass; Gloria M Miele; Denise A Hien; Aimee N C Campbell; Mei-Chen Hu; Nathilee Caldeira; Huiping Jiang; Lisa Litt; Therese Killeen; Mary Hatch-Maillette; Lisa Najavits; Chanda Brown; James A Robinson; Gregory S Brigham; Edward V Nunes Journal: Subst Use Misuse Date: 2012-04-04 Impact factor: 2.164
Authors: Monika E Kolodziej; Patrice M Muchowski; Nayla R Hamdi; Paula Morrissette; Alicen J McGowan; Roger D Weiss Journal: Am J Addict Date: 2011-12-15
Authors: P Todd Korthuis; Jessica Gregg; Wendy E Rogers; Dennis McCarty; Christina Nicolaidis; Joshua Boverman Journal: J Addict Med Date: 2010-12 Impact factor: 3.702
Authors: Iman Parhami; Margarit Davtian; Michael Collard; Jean Lopez; Timothy W Fong Journal: J Behav Health Serv Res Date: 2014-07 Impact factor: 1.505